375 related articles for article (PubMed ID: 31202810)
1. TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.
Suzuki A; Murakami K; Tajima Y; Hara H; Kunugi A; Kimura H
Pharmacol Biochem Behav; 2019 Aug; 183():80-86. PubMed ID: 31202810
[TBL] [Abstract][Full Text] [Related]
2. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological characterization of a novel AMPA receptor potentiator, TAK-137, in rat hippocampal neurons.
Suzuki A; Tajima Y; Kunugi A; Kimura H
Neurosci Lett; 2019 Nov; 712():134488. PubMed ID: 31518676
[TBL] [Abstract][Full Text] [Related]
4. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
[TBL] [Abstract][Full Text] [Related]
5. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765.
Neis VB; Moretti M; Rosa PB; Dalsenter YO; Werle I; Platt N; Kaufmann FN; Rosado AF; Besen MH; Rodrigues ALS
Pharmacol Biochem Behav; 2020 Nov; 198():173020. PubMed ID: 32861641
[TBL] [Abstract][Full Text] [Related]
6. Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant.
Suzuki A; Hara H; Kimura H
Neuropharmacology; 2023 Jan; 222():109308. PubMed ID: 36341809
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR.
Akinfiresoye L; Tizabi Y
Psychopharmacology (Berl); 2013 Nov; 230(2):291-8. PubMed ID: 23732839
[TBL] [Abstract][Full Text] [Related]
9. Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc.
Szewczyk B; Pochwat B; Rafało A; Palucha-Poniewiera A; Domin H; Nowak G
Neuropharmacology; 2015 Dec; 99():517-26. PubMed ID: 26297535
[TBL] [Abstract][Full Text] [Related]
10. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC
J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812
[TBL] [Abstract][Full Text] [Related]
11. Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.
Lin JC; Lee MY; Chan MH; Chen YC; Chen HH
Psychopharmacology (Berl); 2016 Sep; 233(17):3223-35. PubMed ID: 27363702
[TBL] [Abstract][Full Text] [Related]
12. Licorisoflavan A Exerts Antidepressant-Like Effect in Mice: Involvement of BDNF-TrkB Pathway and AMPA Receptors.
Xiao D; Liu L; Li Y; Ruan J; Wang H
Neurochem Res; 2019 Sep; 44(9):2044-2056. PubMed ID: 31278631
[TBL] [Abstract][Full Text] [Related]
13. Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.
Pazini FL; Cunha MP; Rosa JM; Colla AR; Lieberknecht V; Oliveira Á; Rodrigues AL
Mol Neurobiol; 2016 Dec; 53(10):6818-6834. PubMed ID: 26660117
[TBL] [Abstract][Full Text] [Related]
14. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
Pałucha-Poniewiera A; Szewczyk B; Pilc A
Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons.
Park SW; Lee JG; Seo MK; Lee CH; Cho HY; Lee BJ; Seol W; Kim YH
Int J Neuropsychopharmacol; 2014 Nov; 17(11):1831-46. PubMed ID: 24901414
[TBL] [Abstract][Full Text] [Related]
16. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
[TBL] [Abstract][Full Text] [Related]
17. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.
Cavalleri L; Merlo Pich E; Millan MJ; Chiamulera C; Kunath T; Spano PF; Collo G
Mol Psychiatry; 2018 Apr; 23(4):812-823. PubMed ID: 29158584
[TBL] [Abstract][Full Text] [Related]
18. Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice.
Martin AE; Schober DA; Nikolayev A; Tolstikov VV; Anderson WH; Higgs RE; Kuo MS; Laksmanan A; Catlow JT; Li X; Felder CC; Witkin JM
CNS Neurol Disord Drug Targets; 2017; 16(4):492-500. PubMed ID: 28294051
[TBL] [Abstract][Full Text] [Related]
19. Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons.
El Iskandrani KS; Oosterhof CA; El Mansari M; Blier P
J Psychopharmacol; 2015 Jul; 29(7):792-801. PubMed ID: 25759403
[TBL] [Abstract][Full Text] [Related]
20. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
